Assessing Depression in a Geriatric Cancer Population

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00580476

Enrollment

201

Registered

2007-12-24

Start date

2006-09-12

Completion date

2024-09-05

Last updated

2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Prostate Cancer

Keywords

Breast Cancer, Prostate Cancer

Brief summary

The goal of this study is to learn more about how we measure depression in elderly cancer patients (patients aged 70 and older). Depression is one of the most common causes of emotional distress in the elderly and continues to be under-recognized. This is a problem because depression can have a negative impact on quality of life. The symptoms of depression are linked to poor health outcomes and higher costs of health care. In fact, depression is one of the top five concerns facing the elderly today.

Detailed description

We have a few questionnaires that have been used to measure depression, but we do not know how these measures work with people with cancer. This study will help us answer this question. To complete this study, we need people who may or may not be feeling down or depressed. If you choose to take part, you will be asked to do the following: 1. Fill out questionnaires that ask about: * Your age, eduction, race, and income * Your mood In all, these questionnaires will take about 10 minutes to complete. 2. Answer questions about your mood. This will also take about 10 minutes to complete.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

70 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age 70 and older 2. Diagnosis of early or late stage prostate cancer, or diagnosis of early or late stage breast cancer 3. Actively engaged in one of the following cancer treatments: chemotherapy, radiation therapy, hormone therapy 4. Able to provide informed consent 5. Ability to converse, write and read English

Exclusion criteria

1.Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.

Design outcomes

Primary

Measure	Time frame
Test the sensitivity and specificity of the Geriatric Depression Scale-Short Form and two other widely used assessments of depression to detect major and minor depression in a geriatric breast and prostate cancer population.	2 years

Secondary

Measure	Time frame
To develop a cut-off score for the GDS that is specific to a cancer population.	2 years

Countries

United States

Outcome results